Event-Based Models (EBMs) infer biomarker progression from cross-sectional data but typically only as ordinal sequences and rely on rigid model assumptions. We propose , a Transformer architecture that learns both ordinal and continuous event sequences through simulation-based supervised learning. uses two Transformer modules: one treats biomarkers as tokens to infer event sequencing; the other treats patients as tokens, representing each by their per-biomarker abnormality profile, to infer patients’ disease stages. On synthetic benchmarks, reduces normalized Kendall’s Tau distance by 52.89% and staging MAE by 25.33% compared to state-of-the-art SA-EBM, with larger reductions in high-dimensional settings (58.88% and 61.10%). Applied to ADNI, recovers a biologically plausible Alzheimer’s progression: early medial temporal atrophy, followed by amyloid accumulation and cognitive decline, and late-stage tau pathology with terminal acceleration of global neurodegeneration – broadly consistent with established disease models. also eliminates the need to derive custom inference algorithms and enables rapid empirical comparison of generative hypotheses.

生成讲解博客的中文版本

生成AI智能校验的中文版本